Abby Li Selected Research

Palivizumab

6/2018	Palivizumab prophylaxis for respiratory syncytial virus in infants with cystic fibrosis: is there a need?
1/2018	Adherence and outcomes: a systematic review of palivizumab utilization.
5/2017	Comparing First- and Second-year Palivizumab Prophylaxis in Patients With Hemodynamically Significant Congenital Heart Disease in the CARESS Database (2005-2015).
3/2017	First versus second year respiratory syncytial virus prophylaxis in chronic lung disease (2005-2015).
11/2016	Palivizumab Adherence and Outcomes in Canadian Aboriginal Children.
1/2015	Serious Adverse Events in the Canadian Registry of Children Receiving Palivizumab (CARESS) for Respiratory Syncytial Virus Prevention.
6/2014	Respiratory syncytial virus prophylaxis in Down syndrome: a prospective cohort study.
2/2014	Hospitalization for respiratory syncytial virus illness in Down syndrome following prophylaxis with palivizumab.
1/2013	Respiratory-related hospitalizations following prophylaxis in the Canadian registry for palivizumab (2005-2012) compared to other international registries.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Abby Li Research Topics

Disease

4	Dementia (Dementias) 01/2021 - 04/2011
3	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 05/2011
3	Respiratory Syncytial Virus Infections 01/2018 - 01/2013
2	Pain (Aches) 01/2022 - 01/2020
2	Respiratory Tract Infections (Respiratory Tract Infection) 03/2017 - 06/2014
1	Dizziness (Lightheadedness) 01/2020
1	Major Depressive Disorder (Major Depressive Disorders) 01/2020
1	Weight Gain 01/2020
1	Birth Weight (Birth Weights) 01/2019
1	Cystic Fibrosis (Mucoviscidosis) 06/2018
1	Congenital Heart Defects (Congenital Heart Defect) 05/2017
1	Lung Diseases (Lung Disease) 03/2017
1	Infections 11/2016
1	Hypersensitivity (Allergy) 01/2015
1	Down Syndrome (Down's Syndrome) 02/2014

Drug/Important Bio-Agent (IBA)

9	Palivizumab FDA Link 06/2018 - 01/2013
2	Oxygen (Dioxygen)IBA 01/2019 - 03/2017
1	Medical MarijuanaIBA 01/2022
1	Opioid Analgesics (Opioids)IBA 01/2022
1	BenzodiazepinesIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Methylphenidate (Ritalin)FDA LinkGeneric 01/2021
1	Antidepressive Agents (Antidepressants)IBA 01/2020
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2020
1	Pharmaceutical PreparationsIBA 03/2012
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 05/2011
1	Memantine (Namenda)FDA Link 04/2011

Therapy/Procedure

1	Therapeutics 03/2017